JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasame, H. A.
Right arrow Articles by Boyd, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasame, H. A.
Right arrow Articles by Boyd, M. R.

Paradoxical effects of cobaltous chloride and salts of other divalent metals on tissue levels of reduced glutathione and microsomal mixed- function oxidase components

HA Sasame and MR Boyd

Treatment of animals with cobaltous chloride caused decreases in hepatic, pulmonary and renal cytochrome P-450, and alterations in levels of other components of microsomal mixed-function oxidases, which can alter the rate of biotransformation of certain drug substrates. The treatment also caused a striking, dose-dependent elevation in tissue levels of reduced glutathione (GSH), within 2 to 8 hours. The effect of cobalt on GSH occurred in all tested animal species and strains. Actinomycin-D partially prevented the cobalt-stimulated rise in hepatic GSH. Salts of several other divalent metals also produced sharply elevated levels of hepatic GSH, occurring concomitantly with decreased microsomal content of cytochrome P-450. These results suggest that pretreatment of animals with cobaltous chloride, or other divalent metal salts, could alter the disposition of certain toxic, alkylating drug metabolites not only by decreasing the rate of formation of the reactive metabolites, but also by increasing the amount of GSH available for the formation of their less reactive, less toxic, GSH conjugates.

Volume 205, Issue 3, pp. 718-724, 06/01/1978
Copyright © 1978 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Hum Exp ToxicolHome page
K Seth, A K Agrawal, I Date, and P K Seth
The role of dopamine in manganese-induced oxidative injury in rat pheochromocytoma cells
Human and Experimental Toxicology, March 1, 2002; 21(3): 165 - 170.
[Abstract] [PDF]

Home page
 J. Nutr.Home page
G. I. Stangl, D. A. Roth-Maier, and M. Kirchgessner
Vitamin B-12 Deficiency and Hyperhomocysteinemia Are Partly Ameliorated by Cobalt and Nickel Supplementation in Pigs
J. Nutr., December 1, 2000; 130(12): 3038 - 3044.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
S. Body, H. Sasame, and M. Body
High concentrations of glutathione in glandular stomach: possible implications for carcinogenesis
Science, September 7, 1979; 205(4410): 1010 - 1012.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics.